慢性呼吸道疾病中的促炎性细胞因子及其管理
Vivek P Chavda1, Rajashri Bezbaruah2,3, Nasima Ahmed2
1Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad 380009, Gujarat, India.
Cells
|March 26, 2025
概括
肺部炎症涉及细胞因子,这些细胞因子可以使喘和纤维化等肺部疾病恶化. 广泛的抗炎症策略可能比针对单个细胞因子提供更好的治疗效益.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 肺内静止因环境或内源因素而被破坏,引发炎症.
- 细胞因子,信号糖蛋白,调节免疫反应和细胞行为.
- 失调的细胞因子产生会加剧慢性炎症和肺部结构变化.
研究的目的:
- 审查参与肺炎和呼吸道疾病病原发生的细胞因子.
- 研究细胞因子介导的肺炎的向治疗策略.
- 评估广泛的抗炎方法的临床有效性.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 识别关键的细胞因子 (介质蛋白,化学因子,生长因子).
- 分析细胞因子在喘,COPD,肺癌,肺炎和纤维化等疾病中的作用.
主要成果:
- 促炎性细胞因子协调慢性炎症和呼吸道重塑.
- 过度或失调的细胞因子反应会导致不适应的结果.
- 针对特定的细胞因子可能缺乏临床益处;广泛的方法显示出希望.
结论:
- 肺部疾病中的细胞因子概况是多样化的,并且是治疗点.
- 广谱抗炎疗法更有可能在临床上有效.
- 了解细胞因子介导的炎症对于开发新的肺病疗法至关重要.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
320
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
320
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
163
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
163
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.5K


